Cognate antigen directs CD8+ T cell migration to vascularized transplants.

Jeffrey M Walch,Qiang Zeng,Qi Li,Martin H Oberbarnscheidt,Rosemary A Hoffman,Amanda L Williams,David M Rothstein,Warren D Shlomchik,Jiyun V Kim,Geoffrey Camirand,Fadi G Lakkis
DOI: https://doi.org/10.1172/JCI66722
IF: 19.456
2013-01-01
Journal of Clinical Investigation
Abstract:The migration of effector or memory T cells to the graft is a critical event in the rejection Of transplanted organs. The prevailing view is that the key steps involved in T cell migration - integrin-mediated firm adhesion followed by transendothelial migration - are dependent on the activation of G alpha(i)-coupled chemokine receptors on T cells. In contrast to this view, we demonstrated in vivo that cognate antigen was necessary for the firm adhesion and transendothelial migration of CD8(+) effector T cells specific to graft antigens and that both steps occurred independent of G alpha(i) signaling. Presentation of cognate antigen by either graft endothelial cells or bone marrow-derived APCs that extend into the capillary lumen was sufficient for T cell migration. The adhesion and transmigration of antigen-nonspecific (bystander) effector T cells, on the other hand, remained dependent on G alpha(i), but required the presence of antigen-specific effector T cells. These findings underscore the primary role of cognate antigen presented by either endothelial cells or bone marrow-derived APCs in the migration of T cells across endothelial barriers and have important implications for the prevention and treatment of graft rejection.
What problem does this paper attempt to address?